• Biomea Fusion presents Phase II data on icovamenib in type 1 diabetes at ADA meeting Traders Union Thu, 09 Jul 2026 21:10:22 GMT

• biomea fusion inc financial disclosures & sec filings TradingView Sat, 04 Jul 2026 17:02:53 GMT

• biomea fusion q1 2026 earnings: eps beat drives stock rally for clinical-stage biotech - post-earnings drift dars.gov.et Mon, 29 Jun 2026 10:40:17 GMT

• price to earnings forward of biomea fusion, inc. – nasdaq:bmea TradingView Sun, 28 Jun 2026 15:51:32 GMT

• price to sales forward of biomea fusion, inc. – nasdaq:bmea TradingView Sun, 28 Jun 2026 08:50:19 GMT

• price to book forward of biomea fusion, inc. – nasdaq:bmea TradingView Sun, 28 Jun 2026 01:05:47 GMT

• Enterprise value to revenue forward of Biomea Fusion, Inc. – NASDAQ:BMEA TradingView Sat, 27 Jun 2026 22:26:30 GMT

• Insiders Buying Biomea Fusion Might Wish They Invested More, Stock Gains 12% simplywall.st Sat, 27 Jun 2026 13:40:57 GMT

• enterprise value to ebitda forward of biomea fusion, inc. – nasdaq:bmea TradingView Sat, 27 Jun 2026 11:19:45 GMT

• enterprise value to ebit forward of biomea fusion, inc. – nasdaq:bmea TradingView Sat, 27 Jun 2026 09:30:34 GMT

• biomea fusion inc actuals & estimates (nasdaq:bmea) TradingView Fri, 26 Jun 2026 05:43:19 GMT

• COVALENT-112 Phase II data boost momentum for ico, Biomea Fusion pushes first-in-class strategy Traders Union Thu, 25 Jun 2026 17:40:32 GMT

• BMEA Forecast — Price Target — Prediction for 2027 TradingView Thu, 25 Jun 2026 13:45:54 GMT

• H.C. Wainwright Maintains Biomea Fusion(BMEA.US) With Buy Rating, Maintains Target Price $4 Moomoo Wed, 24 Jun 2026 07:00:00 GMT

• biomea fusion inc (bmea) earnings forecast: future eps & revenue growth estimates TradingKey Sun, 21 Jun 2026 07:00:00 GMT

• biomea fusion inc (bmea) technical analysis: support, resistance, indicators & moving averages TradingKey Sun, 21 Jun 2026 07:00:00 GMT

• Biomea Fusion Inc (BMEA) Technical Analysis: Support, Resistance, Indicators & Moving Averages TradingKey Sat, 20 Jun 2026 03:10:16 GMT

• biomea fusion inc (bmea) financial health: profitability & balance sheet analysis TradingKey Sat, 20 Jun 2026 02:52:56 GMT

• biomea fusion inc (bmea) valuation: pe, pb & fair value analysis TradingKey Sat, 20 Jun 2026 00:55:05 GMT

• biomea fusion inc (bmea) risk assessment: volatility, financial risk & investment risk TradingKey Sat, 20 Jun 2026 00:46:44 GMT

• biomea fusion inc (bmea) institutional confidence TradingKey Sat, 20 Jun 2026 00:33:44 GMT

• biomea fusion inc (bmea) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 09:20:42 GMT

• Team Fusion pinpoints this year leading trends at ADA2026 event Traders Union Thu, 18 Jun 2026 07:00:00 GMT

• Biomea Fusion Inc (BMEA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 06:10:06 GMT

• Biomea Fusion Inc (BMEA) Shareholder Structure: Major Shareholders & Institutional Holdings TradingKey Thu, 18 Jun 2026 01:01:03 GMT

• biomea fusion inc (bmea) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:00:00 GMT

• biomea fusion inc (bmea) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 07:00:00 GMT

• number of shareholders of biomea fusion, inc. – nasdaq:bmea TradingView Tue, 16 Jun 2026 19:55:00 GMT

• Biomea Fusion Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline - Earnings Seasonality dars.gov.et Tue, 16 Jun 2026 07:00:00 GMT

• citi maintains biomea fusion(bmea.us) with buy rating, maintains target price $7 Moomoo Fri, 12 Jun 2026 11:42:38 GMT

• Biomea Fusion (BMEA) director granted 196,299 stock options at $1.15 exercise price Stock Titan Fri, 12 Jun 2026 07:00:00 GMT

• Biomea Fusion (BMEA) director receives 173,711-share stock option grant at $1.15 Stock Titan Fri, 12 Jun 2026 07:00:00 GMT

• Biomea Fusion (BMEA) director Ray Sumita granted 196,299 stock options Stock Titan Fri, 12 Jun 2026 07:00:00 GMT

• [Form 4] Biomea Fusion, Inc. Insider Trading Activity Stock Titan Fri, 12 Jun 2026 07:00:00 GMT

• Biomea Fusion (NASDAQ: BMEA) details 2026 director and auditor votes Stock Titan Thu, 11 Jun 2026 07:00:00 GMT

• bmea q1 2026 earnings: narrower-than-expected loss lifts shares - profit inflection point dars.gov.et Thu, 11 Jun 2026 07:00:00 GMT

• bmea: all proposals, including director elections and auditor ratification, were approved TradingView Wed, 10 Jun 2026 17:40:45 GMT

• BMEA: Directors and auditors were approved by majority vote, with results to be filed with the SEC TradingView Wed, 10 Jun 2026 07:00:00 GMT

• piper sandler maintains biomea fusion(bmea.us) with buy rating, maintains target price $7 Moomoo Tue, 09 Jun 2026 11:31:00 GMT

• Biomea Fusion, Inc. (BMEA) Presents at American Diabetes Association (ADA) 86th Scientific Sessions - Slideshow Seeking Alpha Mon, 08 Jun 2026 07:00:00 GMT

• h.c. wainwright maintains biomea fusion(bmea.us) with buy rating, maintains target price $4 Moomoo Mon, 08 Jun 2026 07:00:00 GMT

• biomea fusion unveils new icovamenib data showing durable insulin secretion gains in t1d and t2d Traders Union Sat, 06 Jun 2026 07:00:00 GMT

• biomea fusion shows promising diabetes and obesity drug data, expands phase i study for weight loss therapy. Pluang Fri, 05 Jun 2026 23:56:43 GMT

• New diabetes pills show insulin gains and weight-loss potential at ADA Stock Titan Fri, 05 Jun 2026 07:00:00 GMT

• Biomea Fusion Presents Promising Clinical Data for Icovamenib and Expands Phase I Study of BMF-650 at ADA 2026 Quiver Quantitative Fri, 05 Jun 2026 07:00:00 GMT

• Biomea Fusion shows promising diabetes and obes... Pluang Fri, 05 Jun 2026 07:00:00 GMT

• biomea fusion presents new clinical and translational data for icovamenib at the american diabetes association (“ada”) 86th scient... GlobeNewswire Fri, 05 Jun 2026 07:00:00 GMT

• biomea fusion says icovamenib data show muscle preservation and fat reduction in obesity and diabetes TradingView Fri, 05 Jun 2026 07:00:00 GMT

• bmea: phase ii diabetes trials for a novel menin inhibitor target non-chronic, restorative therapy TradingView Thu, 04 Jun 2026 13:11:03 GMT

• symbol__ stock quote price and forecast CNN Thu, 04 Jun 2026 09:03:24 GMT

• Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide... Investing News Network Wed, 03 Jun 2026 07:00:00 GMT

• New trial pairs icovamenib with semaglutide for weight loss, muscle health Stock Titan Wed, 03 Jun 2026 07:00:00 GMT

• Biomea Fusion to study icovamenib with semaglutide for weight loss Investing.com Wed, 03 Jun 2026 07:00:00 GMT

• bmea technical analysis | trend, signals & chart patterns | biomea fusion inc (nasdaq:bmea) ChartMill Tue, 02 Jun 2026 07:00:00 GMT

• bmea stock price, quote & chart | biomea fusion inc (nasdaq:bmea) ChartMill Tue, 02 Jun 2026 07:00:00 GMT

• bmea q1 2026 earnings: narrower-than-expected loss highlights progress in clinical pipeline - consensus miss rate dars.gov.et Thu, 28 May 2026 07:00:00 GMT

• bmea - biomea fusion inc stock price and quote Finviz Wed, 27 May 2026 09:59:52 GMT

• biomea fusion slides after-hours following stock-and-warrant offering; retail traders see rebound ahead MSN Mon, 25 May 2026 21:08:32 GMT

• biomea fusion slides after-hours following stock-and-warrant offering; retail traders see rebound ahead MSN Sun, 24 May 2026 21:19:56 GMT

• bmea stock price, quote & chart | biomea fusion inc (nasdaq:bmea) ChartMill Mon, 18 May 2026 07:00:00 GMT

• bmea technical analysis | trend, signals & chart patterns | biomea fusion inc (nasdaq:bmea) ChartMill Mon, 18 May 2026 07:00:00 GMT

• biomea fusion, inc. - common stock (nq: bmea FinancialContent Fri, 15 May 2026 05:01:58 GMT

• biomea fusion, inc. - common stock (nq: bmea FinancialContent Thu, 14 May 2026 14:41:18 GMT

• oppenheimer keeps their buy rating on biomea fusion (bmea) The Globe and Mail Thu, 14 May 2026 07:00:00 GMT

• piper sandler maintains biomea fusion(bmea.us) with buy rating, raises target price to $7 Moomoo Wed, 13 May 2026 21:39:40 GMT

• oppenheimer maintains biomea fusion(bmea.us) with buy rating, maintains target price $9 富途牛牛 Wed, 13 May 2026 14:38:52 GMT

• biomea fusion to participate at upcoming investor conferences The Manila Times Wed, 13 May 2026 07:00:00 GMT

• analyst reiterates buy on biomea fusion, maintains $4 price target amid advancing metabolic pipeline TipRanks Tue, 12 May 2026 11:21:33 GMT

• Biomea Fusion to Participate at Upcoming Investor Conferences GlobeNewswire Tue, 12 May 2026 07:00:00 GMT

• h.c. wainwright maintains biomea fusion(bmea.us) with buy rating, maintains target price $4 Moomoo Tue, 12 May 2026 07:00:00 GMT

• piper sandler maintains biomea fusion(bmea.us) with buy rating, raises target price to $7 Moomoo Tue, 12 May 2026 07:00:00 GMT

• biomea fusion completes icovamenib chronic tox studies and posts 52-week follow-up in diabetes pipeline Traders Union Tue, 12 May 2026 03:08:53 GMT

• biomea fusion inc reports results for the quarter ended march 31 - earnings summary TradingView Mon, 11 May 2026 21:44:02 GMT

• biomea fusion q1 net loss narrows as expenses fall TradingView Mon, 11 May 2026 21:05:34 GMT

• biomea fusion 4q loss/shr 17c >bmea Moomoo Mon, 11 May 2026 21:03:00 GMT

• biomea fusion, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Mon, 11 May 2026 21:01:00 GMT

• press release: biomea fusion reports first quarter 2026 financial results and corporate highlights Moomoo Mon, 11 May 2026 20:54:00 GMT

• Biomea diabetes drug shows 52% C-peptide boost at 12 weeks Stock Titan Mon, 11 May 2026 07:00:00 GMT

• BIOMEA FUSION ($BMEA) Releases Q1 2026 Earnings, Stock Rises Quiver Quantitative Mon, 11 May 2026 07:00:00 GMT

• Biomea Fusion (Nasdaq: BMEA) cuts Q1 2026 loss while advancing diabetes and obesity pipeline Stock Titan Mon, 11 May 2026 07:00:00 GMT

• Biomea Fusion, Inc. Q1 2026: Net loss $(12.4)M, EPS $(0.17) — 10-Q Summary TradingView Mon, 11 May 2026 07:00:00 GMT

• Biomea Fusion Announces First Quarter 2026 Financial Results and Corporate Updates on May 11, 2026 geneonline.com Mon, 11 May 2026 07:00:00 GMT

• biomea fusion reports first quarter 2026 financial results and corporate highlights Yahoo Finance Mon, 11 May 2026 07:00:00 GMT

• biomea fusion (bmea) trims q1 2026 loss but flags cash runway only into early 2027 Stock Titan Mon, 11 May 2026 07:00:00 GMT

• biomea fusion inc (nasdaq:bmea) q1 2026 earnings beat and pipeline progress drive cautious optimism ChartMill Mon, 11 May 2026 07:00:00 GMT

• bmea.o technical analysis & stock price forecast Intellectia AI Sat, 09 May 2026 09:04:21 GMT

• biomea fusion options imply 18.9% move in share price post-earnings TipRanks Fri, 08 May 2026 20:06:12 GMT

• bmea technical analysis | trend, signals & chart patterns | biomea fusion inc (nasdaq:bmea) ChartMill Fri, 08 May 2026 07:00:00 GMT

• icovamenib boosts c-peptide secretion in 52-week diabetes trial Traders Union Thu, 07 May 2026 22:18:05 GMT

• biomea fusion options imply 23.1% move in share price post-earnings TipRanks Thu, 07 May 2026 02:34:26 GMT

• this applied materials analyst begins coverage on a bullish note; here are top 5 initiations for tuesday Sahm Wed, 06 May 2026 14:51:11 GMT

• citizens initiates coverage of biomea fusion (bmea) with market outperform recommendation MSN Wed, 06 May 2026 07:31:57 GMT

• biomea fusion announces poster presentations of icovamenib at the american diabetes association (ada) 86th scientific sessions The Manila Times Wed, 06 May 2026 07:00:00 GMT

• biomea fusion to present new icovamenib data at american diabetes association event Traders Union Wed, 06 May 2026 07:00:00 GMT

• biomea fusion initiated with an outperform at citizens TipRanks Tue, 05 May 2026 09:13:59 GMT

• Three diabetes studies put Biomea's icovamenib in ADA late-breakers Stock Titan Tue, 05 May 2026 07:00:00 GMT

• Biomea Fusion Announces Poster Presentations of Icovamenib GlobeNewswire Tue, 05 May 2026 07:00:00 GMT

• Citizens initiates Biomea Fusion stock coverage citing diabetes treatment potential Investing.com Tue, 05 May 2026 07:00:00 GMT

• Biomea Fusion Announces Late-Breaking Poster Presentations on Icovamenib at ADA 86th Scientific Sessions Quiver Quantitative Tue, 05 May 2026 07:00:00 GMT

• biomea fusion to present diabetes drug icovamenib data at ada 2026 conference Pluang Tue, 05 May 2026 07:00:00 GMT

• biomea fusion status update: experts discuss icovamenib’s promise ahead of ada 2026 Yahoo Finance Tue, 05 May 2026 07:00:00 GMT

• citizens initiates coverage of biomea fusion (bmea) with market outperform recommendation MSN Tue, 05 May 2026 07:00:00 GMT

• this applied materials analyst begins coverage on a bullish note; here are top 5 initiations for tuesday Sahm Tue, 05 May 2026 07:00:00 GMT

• citizens jmp initiates biomea fusion(bmea.us) with buy rating, announces target price $9 Moomoo Tue, 05 May 2026 07:00:00 GMT

• biomea fusion (nasdaq:bmea) coverage initiated by analysts at citizens jmp MarketBeat Tue, 05 May 2026 07:00:00 GMT

• biomea fusion options imply 22.0% move in share price post-earnings TipRanks Mon, 04 May 2026 07:00:00 GMT

• u.s. earnings preview: after market close may 1 Moomoo Fri, 01 May 2026 19:31:00 GMT

• biomea fusion, inc. (nasdaq:bmea) receives average rating of "moderate buy" from analysts MarketBeat Fri, 01 May 2026 07:00:00 GMT

• biomea fusion inc expected to post a loss of 24 cents a share - earnings preview TradingView Fri, 01 May 2026 07:00:00 GMT

• bmea stock price, quote & chart | biomea fusion inc (nasdaq:bmea) ChartMill Fri, 01 May 2026 07:00:00 GMT

• icovamenib explored for durable glycemic control in challenging diabetes cases Traders Union Thu, 30 Apr 2026 07:00:00 GMT

• bmea should i buy Intellectia AI Wed, 29 Apr 2026 23:06:47 GMT

• bmea forecast, price target & analyst ratings | biomea fusion inc (nasdaq:bmea) ChartMill Wed, 29 Apr 2026 07:00:00 GMT

• bmea sec filings - biomea fusion, inc. 10-k, 10-q, 8-k forms Stock Titan Tue, 28 Apr 2026 23:49:49 GMT

• biomea fusion (nasdaq:bmea) given buy rating at d. boral capital MarketBeat Tue, 28 Apr 2026 15:29:33 GMT

• biomea fusion | 8-k: current report Moomoo Tue, 28 Apr 2026 12:54:20 GMT

• Biomea Fusion Shares Early Type 1 Diabetes Data as COVALENT-112 Shows C-Peptide Gains with Icovamenib Yahoo Finance Tue, 28 Apr 2026 07:00:00 GMT

• Phase 2 icovamenib T1D data from Biomea Fusion (NASDAQ: BMEA) show 52% C-peptide gain Stock Titan Tue, 28 Apr 2026 07:00:00 GMT

• biomea fusion is maintained at buy by d. boral capital Moomoo Tue, 28 Apr 2026 07:00:00 GMT

• biomea fusion price target maintained with a $12.00/share by d. boral capital Moomoo Tue, 28 Apr 2026 07:00:00 GMT

• biomea fusion, inc. (bmea) discusses top line results from covalent-112 trial of icovamenib in type 1 diabetes - slideshow (nasdaq... Seeking Alpha Tue, 28 Apr 2026 07:00:00 GMT

• h.c. wainwright maintains biomea fusion(bmea.us) with buy rating, maintains target price $4 Moomoo Tue, 28 Apr 2026 07:00:00 GMT

• biomea fusion reports positive phase 2 t1d trial results TipRanks Tue, 28 Apr 2026 07:00:00 GMT

• oppenheimer maintains biomea fusion(bmea.us) with buy rating, maintains target price $9 Moomoo Tue, 28 Apr 2026 07:00:00 GMT

• biomea fusion reports 52 percent c peptide auc gain in phase 2 diabetes trial at week 12 Traders Union Tue, 28 Apr 2026 07:00:00 GMT

• biomea fusion announces positive 52-week results from phase 2 covalent-112 trial in type 1 diabetes showing c-peptide improvement ... markets.businessinsider.com Tue, 28 Apr 2026 06:29:23 GMT

• biomea reports positive type 1 diabetes trial results by investing.com Investing.com Canada Tue, 28 Apr 2026 02:06:14 GMT

• biomea fusion | def 14a: definitive information statements Moomoo Mon, 27 Apr 2026 22:41:34 GMT

• Biomea Fusion Announces Positive 52-Week Results from Phase GlobeNewswire Mon, 27 Apr 2026 07:00:00 GMT

• Biomea reports positive type 1 diabetes trial results Investing.com Mon, 27 Apr 2026 07:00:00 GMT

• in a small t1d trial, 12 weeks of treatment preserved c-peptide for 52 weeks Stock Titan Mon, 27 Apr 2026 07:00:00 GMT

• biomea fusion (nasdaq: bmea) sets 2026 virtual meeting, director votes and deloitte audit Stock Titan Mon, 27 Apr 2026 07:00:00 GMT

• [ars] biomea fusion, inc. sec filing Stock Titan Mon, 27 Apr 2026 07:00:00 GMT

• biomea fusion reports promising 52-week results for icovamenib in phase 2 trial for type 1 diabetes Quiver Quantitative Mon, 27 Apr 2026 07:00:00 GMT

• biomea fusion, inc. announces positive 52-week results from phase 2 covalent-112 trial in type 1 diabetes showing c-peptide improv... marketscreener.com Mon, 27 Apr 2026 07:00:00 GMT

• biomea fusion reports 52 percent c peptide auc gain in phase 2 diabetes trial at week 12 Traders Union Mon, 27 Apr 2026 01:55:32 GMT

• biomea fusion announces pricing of public offering of securities msn.com Sun, 26 Apr 2026 10:02:40 GMT

• biomea fusion files $300m mixed securities shelf MSN Sun, 26 Apr 2026 00:17:04 GMT

• biomea fusion to attend h.c. wainwright global investment conference Sangri Today Sat, 25 Apr 2026 01:40:03 GMT

• biomea fusion announces pricing of public offering of securities MSN Sat, 25 Apr 2026 01:04:08 GMT

• biomea (bmea) stock prediction: what’s next after recent move | q4 2025: profit surprises - rating downgrade Cổng thông tin điện tử Tỉnh Sơn La Thu, 23 Apr 2026 10:42:05 GMT

• biomea (bmea) stock prediction: what’s next after recent move | q4 2025: profit surprises - deceleration risk Cổng thông tin điện tử tỉnh Tây Ninh Wed, 22 Apr 2026 23:36:44 GMT

• biomea fusion, inc. common stock (bmea) stock price today & analysis Gotrade Tue, 21 Apr 2026 20:25:05 GMT

• bmea technical analysis | trend, signals & chart patterns | biomea fusion inc (nasdaq:bmea) ChartMill Tue, 21 Apr 2026 07:00:00 GMT

• biomea fusion aktie: onkologie-aus besiegelt Börse Global Mon, 20 Apr 2026 15:45:36 GMT

• bmea should i buy Intellectia AI Sun, 19 Apr 2026 20:51:54 GMT

• bmea.o pe ratio & valuation, is bmea.o overvalued Intellectia AI Wed, 15 Apr 2026 11:48:50 GMT

• bmea.o stock news today | earnings, events & price alerts Intellectia AI Wed, 15 Apr 2026 11:48:41 GMT

• bmea.o technical analysis & stock price forecast Intellectia AI Wed, 15 Apr 2026 11:44:55 GMT

• trade bmea.o Intellectia AI Wed, 15 Apr 2026 11:17:45 GMT

Biomea Fusion, Inc.
(NASDAQ:BMEA)

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibit...

Website: http://www.biomeafusion.com

Founded: 2017

CEO: Thomas Butler

Sector: Healthcare

Industry: Biotechnology

Healthcare

Share this website to your friends

Biomea Fusion, Inc.(NASDAQ:BMEA)

Biomea Fusion, Inc.
(NASDAQ:BMEA)